Veronica persica Poir. extract - antibacterial, antifungal and scolicidal activities, and inhibitory potential on acetylcholinesterase, tyrosinase, lipoxygenase and xanthine oxidase

Veronica persica (Persian speedwell) is a flowering plant local to Eurasia. In this study, several analyses were done to discover the antimicrobial and scolicidal activities and acetyl cholinesterase (AChE), tyrosinase (TYR), lipoxygenase (LOX), and xanthine oxidase (XO) inhibitory activities of V. persica extract. The results presented that B. subtilis was the most susceptible to the extract (MIC = 40.3 \u3bcg/mL), while P. aeruginosa was the most resistant strain (MIC = 250.9 \u3bcg/mL) among all bacteria evaluated. The extracts demonstrated significant activity versus E. granulosus (P < 0.5) with dose-dependent inhibitions of the protoscolices. The analyzed plant extract exhibited a high AChE and TYR inhibitory activity 55.3% and 52.7% (at the highest utilized dose - 3 mg/mL), respectively. The extract also showed high anti-inflammatory activities in analyses tested. Our research proposed that extract of this plant could be promising to the human health, markedly in the infectious, neurodegenerative and inflammatory disorders

Phytochemical compositions and biological activities of essential oil from Xanthium strumarium L

The chemical composition of the essential oil (EO) from fresh cocklebur (Xanthium strumarium L.) leaves was investigated by GC-MS. The antimicrobial activity of the EO was tested against Gram-positive and Gram-negative bacteria and fungi. Scolicidal activity was assayed against Echinococcus granulosus protoscolices. In total, 34 compounds were identified, accounting for 98.96% of the EO. The main compounds in the EO were cis-\u3b2-guaiene (34.2%), limonene (20.3%), borneol (11.6%), bornyl acetate (4.5%), \u3b2-cubebene (3.8%), sabinene (3.6%), phytol (3.1%), \u3b2-selinene (2.8%), camphene (2.2%), \u3b1-cubebene (2.4%), \u3b2-caryophyllene (1.9%), \u3b1-pinene (1.8%) and xanthinin (1.04%). The antibacterial and antifungal screening of the EO showed that all assayed concentrations significantly inhibited the growth of Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Candida albicans and Aspergillus niger (MIC = 0.5 \ub1 0.1, 1.3 \ub1 0.0, 4.8 \ub1 0.0, 20.5 \ub1 0.3, 55.2 \ub1 0.0 and 34.3 \ub1 0.0 \ub5g/mL, respectively). The scolicidal assay indicated that the EO exhibited a significant activity against E. granulosus protoscolices. To the best of our knowledge, this is the first report on the scolicidal activity of X. strumarium. Because of the emergence of antimicrobial drug resistance, the study of new effective natural chemotherapeutic agents, such as the X. strumarium EO, possibly with low side effects, represents a very promising approach in biomedical research

Susceptibility of Leishmania major to Veronica persica Poir. extracts - In vitro and in vivo assays

Leishmania major is an intracellular parasite generally responsible for cutaneous leishmaniasis (CL), one of the most encountered skin diseases especially in Pakistan, Iran, Iraq, and Saudi Arabia. Current treatment options are not ideal, due to unwanted side effects and increasing resistance and availability is often limited in developing countries. Medicinal plants continue to attract attention because of their beneficial effects in the prevention or/and accelerating the healing process of various diseases. In this study, in vitro and in vivo susceptibility of L. major to Veronica persica Poir. extract, a medicinal plant with many applications, has been evaluated. Antileishmanial activity of plant extract was investigated both on cultured L. major promastigotes and in mice challenged with L. major. Animals were divided into three groups including control (without any treatment), test (treated with plant extract) and glucantime (the reference drug) treated groups. After treatments, skin lesion sizes and body weights of animals were checked during 4 weeks. The potential of the plant extract in decreasing the number of parasites in spleen cells of animals as well as inducing the nitric oxide (NO) production by macrophage cells was also investigated. In vitro tests showed that the plant extract was able to reduce the survival time of promastigotes in a concentration-dependent manner. In vivo experiments also revealed a significant influence of V. persica extracts on accelerating the healing process as well as reducing the overall disease burden in animal model by inducing NO production in macrophage cells. Our findings indicated the promising potential of V. persica extract as an ideal candidate in the treatment of CL caused by L. major

Pullulan gum production from low-quality fig syrup using Aureobasidium pullulans

Pullulan is an important polysaccharide with several potential applications in food science, pharmaceutical and cosmetic industries, but high costs of pullulan production are the main limitation for commercial utilization. Therefore, a cost-effective process for pullulan production was developed using fig syrup as an exclusive nutrient source. In particular, the feasibility of using low quality fig syrup as a supplemental substrate for pullulan gum production by Aureobasidium pullulans was investigated. Fermentation was carried out over a range of fig syrup and sucrose degrees Brix (5-15%). Maximum pullulan gum production was observed after 96h using 12.5% fig syrup, yielding approximately14.06 g/L. This value of pullulan production (14.06 g/L) was higher than the amount of pullulan produced using sucrose as substrate (5.01 g/L). In conclusion, fig syrup was an effective substrate for pullulan production by Aureobasidium pullulans, and, therefore, this byproduct deserves attention for the cost-effective and environmentally friendly pullulan production

Green synthesis of silver nanoparticles (AgNPs) by Lallemantia royleana leaf Extract: Their Bio-Pharmaceutical and catalytic properties

The study of the silver nanoparticles (AgNPs) synthesis based-green methods become more interesting recently due to their low-cost preparation, eco-friendly and non-toxic precursors. The present study approved the ability of the Lallemantia royleana (Benth. in Wall.) Benth. leaf extract for the synthesis of AgNPs for the first time. The synthesized AgNPs were physico-chemical characterized using ultraviolet–visible spectroscopy (UV–Vis), X-ray diffraction (XRD), Fourier Transform-Infrared Spectroscopy (FT-IR), zeta potential and transmission electron microscopy (TEM) analysis. The total phenols, flavonoids, anthocyanin, tannin contents, antioxidant, antimicrobial, anti-inflammatory, anti-arthritic and cytotoxic activities of L. royleana leaf extract and the synthesized AgNPs were investigated. The biocatalytic activity of prepared AgNPs was assessed on methylene blue as a pollutant organic dye. The TEM examination showed that the synthesized AgNPs were predominantly spherical with some mixed shapes and crystalline with average size 34.47 ± 1.6 nm, and showed a localized surface plasmon resonance (LSPR) peak at 425 nm. The zeta potential value was −24.1 mV indicating the stability of produced AgNPs. The new prepared AgNPs have lower total phenols, flavonoids, anthocyanin, tannin contents than L. royleana leaf extract. In addition, the new prepared AgNPs demonstrated the higher DPPH radical scavenging activity (87 %) and the ABTS radical scavenging activity (77 %) at the maximum prepared concentration of 250 μg mL−1 as compared to the L. royleana leaf extract (62 % and 58 %, respectively). The produced AgNPs also exhibited the higher antimicrobial activity against both the Gram-positive (Staphylococcus aureus and Bacillus cereus) and the Gram-negative (Escherichia coli and Shigella flexneri) bacteria and the Candida strains (Candida glabrata and Candida albicans) as compared to the L. royleana leaf extract. The resulting AgNPs indicated a dose-dependent anti-inflammatory effect on human red-blood cell (RBC) membrane stabilization assay and had more activity (72 %) compared to the L. royleana leaf extract (61 %) at 250 µg mL−1. The prepared AgNPs showed promising in vitro anti-arthritic activity evaluated by 73 % compared to 58 % in case of L. royleana leaf extract. The new produced AgNPs showed the higher cytotoxic effect against the human hepatoma (Hep-G2) and the human breast (MCF-7) cancer cells compared to the L. royleana leaf extract with 79.3 % and 77.2 % at 250 µg/mL, respectively. The obtained results revealed also that the green synthesized AgNPs were capable to catalyze MB dye. Therefore, the obtained results provide a promising route of the green synthesis of AgNPs using L. royleana leaf extract with considerable biopharmaceuticals and catalytic applications

In vitro and in vivo assessment of free radical scavenging and antioxidant activities of Veronica persica Poir

With the appearance of new disorders along with inability of some conventional therapies for the treatment of diseases without any side effects, the discovery of safe and efficient therapeutic agents is of utmost importance in the medical area. In this context, medicinal plants as promising therapeutic candidates can provide a reliable and efficient profile. Since free radicals are at the center of various disorder pathways, reducing their production or complete removal of these chemical species could be advantageous for prevention and treatment of many diseases. In this experiment, free radical scavenging and antioxidant activities of Veronica persica Poir., a known medicinal plant, were evaluated using in vitro and in vivo assays. Chemical characterization results showed a high phenolic content in the V. persica methanol extract. In addition, in vitro assays including DPPH radical-scavenging assay, nitric oxide-scavenging activity assay, hydrogen peroxide scavenging test and bleomycin-dependent DNA damage test revealed significant antioxidant power and radical scavenging capacity of this plant. In accordance, in vivo experiments showed inhibitory effects of the methanol extract on lipid peroxidation, a main cause of cell damage. Our findings revealed the promising potential of this plant in reducing free radicals through different pathways. Moreover, our data suggested a correlation between the high phenolic content of the V. persica extract and its free radical scavenging and antioxidant activities

Pulicaria vulgaris Gaertn. Essential oil : an alternative or complementary treatment for Leishmaniasis

Leishmaniasis is a neglected parasitic protozoal disease that affects approximately 12 million people and represents a public health problem in Iran. The objectives of this study were to obtain the essential oil (EO) from Pulicaria vulgaris Gaertn. growing in Iran and to carry out in-vitro antileishmanial screening of the EO against promastigotes of Leishmania major and Leishmania infantum. The EO from the aerial parts of P. vulgaris was extracted by hydrodistillation. Serial dilutions of the EO were screened for in-vitro antileishmanial activity using 96-well microtiter plates. The P. vulgaris EO was active against the promastigote forms of L. major and L. infantum, with IC 50 values of 244.70 and 233.65 \u3bcg/mL, respectively. Pulicaria vulgaris EO may serve as an alternative or complementary treatment for leishmaniasis

Antioxidants: Positive or Negative Actors?

The term "antioxidant" is one of the most confusing definitions in biological/medical sciences. In chemistry, "antioxidant" is simply conceived "a compound that removes reactive species, mainly those oxygen-derived", while in a cell context, the conceptual definition of an antioxidant is poorly understood. Indeed, non-clinically recommended antioxidants are often consumed in large amounts by the global population, based on the belief that cancer, inflammation and degenerative diseases are triggered by high oxygen levels (or reactive oxygen species) and that through blocking reactive species production, organic unbalances/disorders can be prevented and/or even treated. The popularity of these chemicals arises in part from the widespread public mistrust of allopathic medicine. In fact, reactive oxygen species play a dual role in dealing with different disorders, since they may contribute to disease onset and/or progression but may also play a key role in disease prevention. Further, the ability of the most commonly used supplements, such as vitamins C, E, selenium, and herbal supplements to decrease pathologic reactive oxygen species is not clearly established. Hence, the present review aims to provide a nuanced understanding of where current knowledge is and where it should go.Antoni Sureda acknowledges the support of Institute of Health Carlos III (Project CIBEROBNCB12/03/30038). Natália Martins thank to Portuguese Foundation for Science and Technology (FCT–Portugal) for the Strategic project ref. UID/BIM/04293/2013 and “NORTE2020-Programa Operacional Regional do Norte” (NORTE-01-0145-FEDER-000012)

Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts

Veronica genus (Plantaginaceae) is broadly distributed in different habitats. In this study, the inhibitory activity of free soluble and conjugated phenolic extracts of Veronica persica on key enzymes associated to type 2 diabetes (\u3b1-glucosidase and \u3b1-amylase) and hypertension (angiotensin I converting enzyme, ACE) was assessed, as well as their antioxidant power. Our results showed that both the extracts inhibited \u3b1-amylase, \u3b1-glucosidase and ACE in a dose-dependent manner. In particular, free phenolic extract significantly (P<0.05) inhibited \u3b1-glucosidase (IC50 532.97 \ub5g/mL), whereas conjugated phenolic extract significantly (P<0.05) inhibited \u3b1-amylase (IC50 489.73 \ub5g/mL) and ACE (290.06 \ub5g/mL). The enzyme inhibitory activities of the extracts were not associated with their phenolic content. Anyway, the inhibition of \u3b1-amylase, \u3b1-glucosidase and ACE, along with the antioxidant capacity of the phenolic-rich extracts, could represent a putative mechanism through which V. persica exerts its antidiabetes and antihypertension effects

Antibacterial potential of Saussurea obvallata petroleum ether extract: A spiritually revered medicinal plant

Uttarakhand Himalayan region holds Asteraceae or Compositae as the largest family of flowering, medicinal and aromatic plants. Species belonging to this family rises from low altitude to the alpine region. Among Asteraceae, Saussurea obvallata (DC.) Edgew. is widely used in several indigenous systems of medicine. Flowers, leaves and rhizomes of S. obvallata are used for several traditional, religious, therapeutic and ornamental purposes. Aim of this study was to determine the chemical composition and antibacterial efficacy of petroleum ether extract (PEE) of S. obvallata. Gas chromatography-mass spectrometry (GC-MS) analysis was used for identifying phytochemicals present in the plant extract. Furthermore, the PEE was assessed for in-vitro antibacterial activity against selected Gram positive and negative strains. Structure of squalene and \u3b1-linolenic acid methyl ester were identified in PEE by GC-MS analysis, by comparing the results obtained with NIST library and literature reports. PEE exhibited significant activity against Staphylococcus aureus, Escherichia coli, Bacillus cereus, Bacillus subtilis with IC50 value of 87.2 \ub1 1.6, 98.4 \ub1 1.1 and 90.2 \ub1 1.8 \u3bcg/ml, respectively. These results showed that squalene and a-linolenic acid derivative identified in S. obvallata may be responsible for the observed antibacterial activity. To the best of our knowledge, this is the first report focused on the chemical composition and antibacterial activity of S. obvallata